It is well known that the rate of progression from infection to death increases steadily with age (Todd et al. 2007) – this method alerts us to the corresponding importance of age as a determinant of ART need, a factor that tends to be overlooked if it is assumed that a fixed proportion of treatment naive HIV-infected people have CD4 counts low enough to qualify for ART. The gene discussed is CD4; the disease is infection.